FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Freenome, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 15, 2026
$12.57+0.82 (+6.98%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Freenome's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| One Fin Capital GP LLC | 843,482 | 9.50% | 13G (passive) amendment | Mar 31, 2026 |
| Peter Kolchinsky | 750,000 | 8.40% | 13D (active) | Dec 5, 2025 |
| RTW Investments, LP | 742,500 | 8.30% | 13G (passive) | Sep 30, 2024 |
| Chun R. Ding | 716,645 | 8.00% | 13G (passive) | Jan 6, 2026 |
| ADAR1 Capital Management, LLC | 674,695 | 8.30% | 13G (passive) amendment | Jun 30, 2026 |
| 683 Capital Partners, LP | 640,894 | 7.19% | 13G (passive) amendment | Dec 31, 2025 |
| Holocene Advisors, LP | 625,173 | 7.02% | 13G (passive) | Dec 31, 2025 |
| David MacKnight | 603,072 | 6.80% | 13G (passive) | Jan 6, 2026 |
| Aberdeen Group plc | 578,565 | 6.49% | 13G (passive) | Apr 1, 2026 |
| Benjamin A. Horowitz | 5,571,599 | 5.20% | 13G (passive) | Jul 20, 2026 |
| Steven A. Cohen | 465,000 | 5.70% | 13G (passive) | Jul 7, 2026 |
| Daniel Schneeberger | 456,720 | 5.10% | 13G (passive) amendment | Dec 31, 2025 |
| Michael Seth Altman | 2,442,500 | 22.10% | 13G (passive) | Sep 30, 2024 |
| Roche Holding Ltd | 18,692,766 | 17.40% | 13G (passive) | Jul 20, 2026 |
| RA Capital Management, L.P. | 15,367,270 | 14.30% | 13D (active) amendment | Jul 20, 2026 |
| Joseph Edelman | 10,871,847 | 10.10% | 13G (passive) | Jul 20, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Aaron Matthew Elliott | Chief Executive Officer, Director | 345,976 | 3.35% | Sep 4, 2026 |
| Riley Charles Ennis | Chief Product Officer | 2,864,366 | 27.77% | Jul 27, 2026 |
| Cheng-Ho Jimmy Lin | Chief Scientific Officer | 410,154 | 3.98% | Jul 27, 2026 |
| Linh H. Le | Chief Financial Officer | 64,294 | 0.62% | Jul 27, 2026 |
| Deepika Pakianathan | Director | 13,918 | 0.13% | Jul 27, 2026 |
| Randal W. Scott | Director | 104,204 | 1.01% | Jul 27, 2026 |
| Oort Douglas M. Van | Director | 20,867 | 0.20% | Jul 27, 2026 |
| Ann Catherine Costello | Director | – | – | Jul 27, 2026 |
| Carole Nuechterlein | Director | – | – | Jul 27, 2026 |
| Capital Healthcare Fund LP RA | Director | – | – | Jul 22, 2026 |
| Rajeev M. Shah | Director | 750,000 | 7.27% | Jul 22, 2026 |
| RA Capital Nexus Fund III, L.P. | Director | – | – | Jul 22, 2026 |
| Peter Kolchinsky | Director | – | – | Jul 22, 2026 |
| RA Capital Nexus Fund, L.P. | Director | 1,245,068 | 12.07% | Jul 22, 2026 |
| Ra Capital Management, L.P. | Director | – | – | Jul 22, 2026 |
| RA Capital Nexus Fund II, L.P. | Director | – | – | Jul 22, 2026 |
| Harlan Waksal | – | 30,000 | 0.29% | Jul 29, 2026 |
| Kenneth Song | – | 30,000 | 0.29% | Jul 24, 2026 |
| Capital Solutions Holdings Perceptive | – | 2,638,750 | 25.59% | Jul 23, 2026 |
| Advisors Llc Perceptive | 10% owner | – | – | Jul 22, 2026 |
| Joseph Edelman | 10% owner | – | – | Jul 22, 2026 |
| Life Sciences Master Fund Ltd Perceptive | 10% owner | 12,582,912 | 122.00% | Jul 22, 2026 |
| Adam Leo Stone | – | 2,638,750 | 25.59% | Jul 22, 2026 |
| Mark C. McKenna | – | 30,000 | 0.29% | Jul 22, 2026 |
| Michael Seth Altman | – | 2,638,750 | 25.59% | Jul 22, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Aaron Matthew Elliott Chief Executive Officer, Director | Sep 2, 2026 | Tax withholding | −71,920 | $15.25 | $1.10M | 345,976 |
| Harlan Waksal – | Jul 20, 2026 | Conversion | +30,000 | – | – | 30,000 |
| Kenneth Song – | Jul 20, 2026 | Conversion | +30,000 | – | – | 30,000 |
| Capital Solutions Holdings Perceptive – | Jul 20, 2026 | Conversion | +2,066,250 | – | – | 2,352,500 |
| Life Sciences Master Fund Ltd Perceptive 10% owner | Jul 20, 2026 | Award | +5,500,000 | $10.00 | $55.00M | 10,871,847 |
| Michael Seth Altman – | Jul 20, 2026 | Conversion | +2,066,250 | – | – | 2,352,500 |
| Mark C. McKenna – | Jul 20, 2026 | Conversion | +30,000 | – | – | 30,000 |
| Adam Leo Stone – | Jul 20, 2026 | Conversion | +2,066,250 | – | – | 2,352,500 |
| RA Capital Nexus Fund, L.P. Director | Jul 20, 2026 | Award | +336,965 | $10.00 | $3.37M | 1,245,068 |
| RA Capital Nexus Fund, L.P. Director | Jul 20, 2026 | Award | +4,918,411 | $10.00 | $49.18M | 12,230,122 |
| RA Capital Nexus Fund, L.P. Director | Jul 20, 2026 | Award | +367,427 | – | – | 367,427 |
| RA Capital Nexus Fund, L.P. Director | Jul 20, 2026 | Award | +908,103 | – | – | 908,103 |
| RA Capital Nexus Fund, L.P. Director | Jul 20, 2026 | Award | +553,703 | – | – | 553,703 |
| RA Capital Nexus Fund, L.P. Director | Jul 20, 2026 | Award | +970,950 | – | – | 970,950 |
| RA Capital Nexus Fund, L.P. Director | Jul 20, 2026 | Award | +6,561,711 | – | – | 7,311,711 |
| Capital Solutions Holdings Perceptive 10% owner | Jun 13, 2024 | Other | +286,250 | $10.00 | $2.86M | 286,250 |
| Michael Seth Altman Chief Business Officer, Director, 10% owner | Jun 13, 2024 | Award | +286,250 | $10.00 | $2.86M | 286,250 |
| Adam Leo Stone Chief Executive Officer, Director, 10% owner | Jun 13, 2024 | Award | +286,250 | $10.00 | $2.86M | 286,250 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.